Functional recovery after spinal cord injury (SCI) remains challenging, requiring therapeutic targets. Here, we show that doublecortin-like kinase 1 (DCLK1) is upregulated after SCI in mice. Pharmacological inhibition of DCLK1 with DCLK1-IN-1 improved motor recovery, reduced glial scar formation and fibrosis, and preserved neurons at the lesion site. Mechanistically, we identified the microtubule-severing protein KATNA1 as a downstream target of DCLK1. DCLK1 directly phosphorylated KATNA1 at threonine 118 (T118), suppressing its microtubule-severing activity. DCLK1 overexpression inhibited, whereas DCLK1 knockdown or inhibition enhanced KATNA1 function. The T118D mutation reduced KATNA1 activity, while T118A resisted DCLK1-mediated suppression. In neurons, DCLK1 inhibited KATNA1-induced neurite outgrowth, whereas DCLK1 inhibition restored this effect. Together, these results identify DCLK1 as a promising therapeutic target for SCI and reveal a mechanism by which DCLK1 regulates KATNA1 phosphorylation to modulate microtubule severing and neurite outgrowth.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: